Basit öğe kaydını göster

GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients

dc.contributor.authorYumuk, P. F.
dc.contributor.authorSezer, A.
dc.contributor.authorErman, M.
dc.contributor.authorTural, D.
dc.contributor.authorTurna, H. Z.
dc.contributor.authorMazieres, J.
dc.contributor.authorDudnik, E.
dc.contributor.authorReguart, N.
dc.contributor.authorCamidge, R.
dc.contributor.authorNg, T. L.
dc.contributor.authorŞENLER, FİLİZ ÇAY
dc.contributor.authorBeypinar, I.
dc.contributor.authorYazilitas, D.
dc.contributor.authorDemirkazik, A.
dc.contributor.authorKaraoglu, A.
dc.contributor.authorOkutur, K.
dc.contributor.authorCOŞKUN, HASAN ŞENOL
dc.contributor.authorSendur, M. A. Nahit
dc.contributor.authorIsikdogan, A.
dc.contributor.authorCabuk, D.
dc.contributor.authorCinkir, H. Y.
dc.contributor.authorYildiz, I.
dc.contributor.authorKaplan, M. A.
dc.contributor.authorOzyilkan, O.
dc.contributor.authorOztop, I.
dc.contributor.authorOlmez, O. F.
dc.contributor.authorAydin, K.
dc.contributor.authorAydiner, A.
dc.contributor.authorMeydan, N.
dc.contributor.authorGrinberg, R.
dc.contributor.authorRoisman, L.
dc.contributor.authorDemirci, U.
dc.contributor.authorChristopoulos, P.
dc.contributor.authorCicin, I.
dc.contributor.authorBasal, F. Bugdayci
dc.contributor.authorYilmaz, C.
dc.contributor.authorFedor, M.
dc.contributor.authorKorkmaz, T.
dc.contributor.authorPaydas, S.
dc.contributor.authorGautschi, O.
dc.contributor.authorZirtiloglu, A.
dc.contributor.authorEralp, Y.
dc.contributor.authorPeled, N.
dc.contributor.authorGillis, R.
dc.contributor.authorKilickap, S.
dc.contributor.authorFroesch, P.
dc.contributor.authorOrlov, S.
dc.contributor.authorFilippova, E.
dc.date.accessioned2021-12-10T11:35:49Z
dc.date.available2021-12-10T11:35:49Z
dc.date.issued2021
dc.identifier.citationPeled N., Gillis R., Kilickap S., Froesch P., Orlov S., Filippova E., Demirci U., Christopoulos P., Cicin I., Basal F. B. , et al., "GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients", JOURNAL OF THORACIC ONCOLOGY, cilt.16, sa.3, 2021
dc.identifier.issn1556-0864
dc.identifier.othervv_1032021
dc.identifier.otherav_881c3d6e-8ab4-4712-8221-dc03217cc92d
dc.identifier.urihttp://hdl.handle.net/20.500.12627/172211
dc.language.isoeng
dc.subjectGöğüs Hastalıkları ve Allerji
dc.subjectİç Hastalıkları
dc.subjectOncology
dc.subjectOnkoloji
dc.subjectHealth Sciences
dc.subjectPulmonary and Respiratory Medicine
dc.subjectRespiratory Care
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectSOLUNUM SİSTEMİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.titleGLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients
dc.typeMakale
dc.relation.journalJOURNAL OF THORACIC ONCOLOGY
dc.contributor.departmentSoroka Med Ctr , ,
dc.identifier.volume16
dc.identifier.issue3
dc.contributor.firstauthorID2622028


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster